Catalog Number |
ACM918633871 |
CAS |
918633-87-1 |
Structure |
|
IUPAC Name |
2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine |
Synonyms |
evofosfamide;TH-302;918633-87-1;TH 302;TH302;n,n'-bis(2-bromoethyl)phosphorodiamidic acid (1-methyl-2-nitro-1h-imidazol-5-yl)methyl ester;UNII-8A9RZ3HN8W;8A9RZ3HN8W;compound 3b;HAP-302;TH-302; Evofosfamide;HAP-302;2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine;Phosphorodiamidic acid, N,N'-bis(2-bromoethyl)-, (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester;Phosphorodiamidic acid, N,N'-bis(2-bromoethyl)-, (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester.;Evofosfamide [USAN:INN];Evofosfamide(TH 302);Evofosfamide(TH-302);C9H16Br2N5O4P;cc-588;CHEMBL260046;Evofosfamide (JAN/USAN/INN);GTPL8695;SCHEMBL2357174;SCHEMBL15691894;DTXSID60238721;AMY16615;BCP06074;EX-A1740;s2757;ZINC29053729;AKOS026673946;ACN-037524;CCG-269225;CS-0616;DB06091;SB17116;AC-29025;AK198685;AS-74462;HY-10535;FT-0696771;X5809;J3.504.735B;D10704;W-5941;J-523214;Q7670203;(1-Methyl-2-nitro-1H-imidazol-5-yl)methyl N,N'-bis(2-bromoethyl)phosphorodiamidate;(2-bromoethyl)({[(2-bromoethyl)amino][(1-methyl-2-nitro-1H-imidazol-5-yl)methoxy]phosphoryl})amine |
Molecular Weight |
449.04g/mol |
Molecular Formula |
C9H16Br2N5O4P |
Canonical SMILES |
CN1C(=CN=C1[N+](=O)[O-])COP(=O)(NCCBr)NCCBr |
InChI |
InChI=1S/C9H16Br2N5O4P/c1-15-8(6-12-9(15)16(17)18)7-20-21(19,13-4-2-10)14-5-3-11/h6H,2-5,7H2,1H3,(H2,13,14,19) |
InChI Key |
UGJWRPJDTDGERK-UHFFFAOYSA-N |
Complexity |
374 |
Covalently-Bonded Unit Count |
1 |
Exact Mass |
448.92862g/mol |
Heavy Atom Count |
21 |
Hydrogen Bond Acceptor Count |
7 |
Monoisotopic Mass |
446.93067g/mol |
Rotatable Bond Count |
9 |
Topological Polar Surface Area |
114Ų |
UNII |
8A9RZ3HN8W |
X Log P3 |
0.6 |